These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27409277)

  • 1. Pharmaceutical patent law: expert perspectives from around the globe.
    Komatani TS
    Pharm Pat Anal; 2016 Jul; 5(4):195-7. PubMed ID: 27409277
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent law protection of inventions in medicine and pharmaceutical industry.
    Miladinović Z; Varga S; Radojković M
    Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528
    [No Abstract]   [Full Text] [Related]  

  • 3. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 4. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 5. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives.
    Altman D; Sweeney C; Yasui T
    Pharm Pat Anal; 2014 Sep; 3(5):469-73. PubMed ID: 25374314
    [No Abstract]   [Full Text] [Related]  

  • 9. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent protection in Europe of pharmaceuticals found to have a further medical indication.
    Cockbain J
    Pharm Pat Anal; 2012 Mar; 1(1):17-8. PubMed ID: 24236708
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced scope for extension of patent term for pharmaceuticals under Australian law.
    Lyons M; Stark A
    Pharm Pat Anal; 2015; 4(5):351-5. PubMed ID: 26490425
    [No Abstract]   [Full Text] [Related]  

  • 12. Big pharma in the dock over patent law plot in South Africa.
    Baleta A
    Lancet; 2014 Feb; 383(9916):499. PubMed ID: 24516881
    [No Abstract]   [Full Text] [Related]  

  • 13. Korea: the new first battleground for the high stakes poker game of pharmaceutical patent litigation.
    Choe JY; Yoon KA; Lee S
    Pharm Pat Anal; 2015; 4(6):409-13. PubMed ID: 26580988
    [No Abstract]   [Full Text] [Related]  

  • 14. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract]   [Full Text] [Related]  

  • 15. Patenting pharmaceuticals in China.
    Han W; Luo J
    Pharm Pat Anal; 2016 Jul; 5(4):249-59. PubMed ID: 27338759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plausibility in patent law: an unsettled concept.
    Crawford C; Reynolds L
    Pharm Pat Anal; 2016 Sep; 5(5):289-93. PubMed ID: 27573248
    [No Abstract]   [Full Text] [Related]  

  • 17. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 18. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
    Xu Z; Chen W
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual property rights and the Canadian pharmaceutical marketplace: where do we go from here?
    Lexchin J
    Int J Health Serv; 2005; 35(2):237-56. PubMed ID: 15932005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How high is too high for the threshold on patent utility?
    Sklan A
    Pharm Pat Anal; 2012 Jul; 1(3):237. PubMed ID: 24236834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.